IFITM1 and COVID-19: Notably, as shown in Fig. 2A, in our cohorts we found that IFITM1 was downregulated in PBMCs from patients with influenza, but not in the HC and COVID-19 groups, contrasting with the patterns observed in the data from the HPA dataset, although the differences were not statistically significant.